285 related articles for article (PubMed ID: 25505502)
1. Cell-based Models To Investigate Tau Aggregation.
Lim S; Haque MM; Kim D; Kim DJ; Kim YK
Comput Struct Biotechnol J; 2014 Nov; 12(20-21):7-13. PubMed ID: 25505502
[TBL] [Abstract][Full Text] [Related]
2. Visualization of Tau⁻Tubulin Interaction in a Living Cell Using Bifluorescence Complementation Technique.
Shin S; Lim S; Jeong H; Kwan LT; Kim YK
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274285
[TBL] [Abstract][Full Text] [Related]
3. Tumor-suppressor PTEN affects tau phosphorylation, aggregation, and binding to microtubules.
Zhang X; Li F; Bulloj A; Zhang YW; Tong G; Zhang Z; Liao FF; Xu H
FASEB J; 2006 Jun; 20(8):1272-4. PubMed ID: 16645045
[TBL] [Abstract][Full Text] [Related]
4. Tau Pathology in Parkinson's Disease.
Zhang X; Gao F; Wang D; Li C; Fu Y; He W; Zhang J
Front Neurol; 2018; 9():809. PubMed ID: 30333786
[TBL] [Abstract][Full Text] [Related]
5. Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease.
Marcus JN; Schachter J
J Neurogenet; 2011 Dec; 25(4):127-33. PubMed ID: 22091726
[TBL] [Abstract][Full Text] [Related]
6. Tau Oligomers Neurotoxicity.
Niewiadomska G; Niewiadomski W; Steczkowska M; Gasiorowska A
Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33418848
[TBL] [Abstract][Full Text] [Related]
7. Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies.
Venkatramani A; Panda D
Int J Biol Macromol; 2019 Jul; 133():473-483. PubMed ID: 31004638
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Pathophysiological Actions of Tau Oligomers: A Critical Review of Current Electrophysiological Approaches.
Hill E; Wall MJ; Moffat KG; Karikari TK
Front Mol Neurosci; 2020; 13():155. PubMed ID: 32973448
[TBL] [Abstract][Full Text] [Related]
9. Tau aggregation is a therapeutic target for Alzheimer's disease.
Takashima A
Curr Alzheimer Res; 2010 Dec; 7(8):665-9. PubMed ID: 20678070
[TBL] [Abstract][Full Text] [Related]
10. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
Navarrete LP; Pérez P; Morales I; Maccioni RB
Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
[TBL] [Abstract][Full Text] [Related]
11. Visualization of soluble tau oligomers in TauP301L-BiFC transgenic mice demonstrates the progression of tauopathy.
Shin S; Kim D; Song JY; Jeong H; Hyeon SJ; Kowall NW; Ryu H; Pae AN; Lim S; Kim YK
Prog Neurobiol; 2020 Feb; ():101782. PubMed ID: 32105751
[TBL] [Abstract][Full Text] [Related]
12. Phospho-Tau Bar Code: Analysis of Phosphoisotypes of Tau and Its Application to Tauopathy.
Kimura T; Sharma G; Ishiguro K; Hisanaga SI
Front Neurosci; 2018; 12():44. PubMed ID: 29467609
[TBL] [Abstract][Full Text] [Related]
13. Neurofibrillary tangles mediated human neuronal tauopathies: insights from fly models.
Sarkar S
J Genet; 2018 Jul; 97(3):783-793. PubMed ID: 30027909
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
Iqbal K; Grundke-Iqbal I
Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
[TBL] [Abstract][Full Text] [Related]
15. [Neuropathology of tauopathy].
Yoshida M
Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
[TBL] [Abstract][Full Text] [Related]
16. Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble Tau
Ondrejcak T; Klyubin I; Corbett GT; Fraser G; Hong W; Mably AJ; Gardener M; Hammersley J; Perkinton MS; Billinton A; Walsh DM; Rowan MJ
J Neurosci; 2018 Dec; 38(50):10595-10606. PubMed ID: 30355631
[TBL] [Abstract][Full Text] [Related]
17. Are tau aggregates toxic or protective in tauopathies?
Cowan CM; Mudher A
Front Neurol; 2013; 4():114. PubMed ID: 23964266
[TBL] [Abstract][Full Text] [Related]
18. In vitro aggregation assays using hyperphosphorylated tau protein.
Sui D; Liu M; Kuo MH
J Vis Exp; 2015 Jan; (95):e51537. PubMed ID: 25590418
[TBL] [Abstract][Full Text] [Related]
19. Identification of an ERK Inhibitor as a Therapeutic Drug Against Tau Aggregation in a New Cell-Based Assay.
Siano G; Caiazza MC; Ollà I; Varisco M; Madaro G; Quercioli V; Calvello M; Cattaneo A; Di Primio C
Front Cell Neurosci; 2019; 13():386. PubMed ID: 31496937
[TBL] [Abstract][Full Text] [Related]
20. MARKing tau for tangles and toxicity.
Drewes G
Trends Biochem Sci; 2004 Oct; 29(10):548-55. PubMed ID: 15450610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
